Combatting Antimicrobial Resistance

Reporting Organization:WHO - World Health Organization
Total Budget ($CAD):$ 9,000,000
Timeframe: March 10, 2017 - August 31, 2018
Status: Completion
Contact Information: Unspecified

Partner & Funder Profiles

Reporting Organization

WHO - World Health Organization

Participating Organizations


Funders (Total Budget Contribution)

Return to top


Region - Total Budget Allocation

Sub-Saharan Africa - $ 2,637,000.00 (29.30%)

South America - $ 2,088,000.00 (23.20%)

Southeast Asia - $ 999,000.00 (11.10%)

Central America - $ 909,000.00 (10.10%)

South Asia - $ 819,000.00 (9.10%)

East Asia - $ 729,000.00 (8.10%)

Central Asia - $ 459,000.00 (5.10%)

North Africa - $ 360,000.00 (4.00%)

Return to top

Areas of Focus

Health - Total Budget Allocation

Infectious & Communicable Diseases (50 %)

Other - Total Budget Allocation

Law, Governance & Public Policy (50 %)

Return to top


This project aims to decrease the impact of antimicrobial resistance (AMR), particularly in low- and middle-income countries. Interventions take place across the first four objectives of the Global Action Plan on AMR, which focus on increasing awareness of AMR as a public health threat; improving capacity to monitor AMR patterns, consumption and use; strengthening capacity in infection prevention and control; and strengthening systems to optimize use of antibiotics. The project also includes a component that reinforces linkages to combat AMR across the World Health Organization, with Member States and partners. The Public Health Agency of Canada is a technical partner in this project.

Return to top

Target Population

Gender and age: Unspecified
Total Direct Population: Unspecified
Return to top



Return to top

Results & Indicators

Expected Results

The expected intermediate outcomes of this project include: (1) enhanced coordination and evidence-based policy-making and planning among national and international actors; and (2) enhanced responsible and effective use of antibiotics at hospital and community level in selected low- and middle-income countries.

Achieved Results

Results achieved by WHO through the support of the Government of Canada and other international donors in 2017-2018 include: (1) strengthened health systems in low- and middle-income countries through the development of national action plans (NAPs) on antimicrobial resistance (AMR) and improvements in the prevention and treatment of infectious diseases; (2) improved data collection on and knowledge around the use of antimicrobial drugs to inform policy and practice and implement NAPs; and (3) strengthened global AMR surveillance systems to guide appropriate action on the consumption, use, quality and safety of medicines to ensure the ability to treat and prevent infectious diseases.


  • None Selected
Return to top
Return to top

Associated Projects (If applicable)

Return to top